Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma. (4th November 2015) - Farren, Matthew R; Shakya, Reena; Hennessey, Rebecca; Mace, Thomas; Yang, Jennifer; Elnaggar, Omar; Young, Gregory; Landesman, Yosef; Carlson, Robert; Elloul, Sivan; Crochiere, Marsha; Burd, Christin; et al.